Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06644469

Whole Body Vibration in Middle Aged Men

This study aims of this clinical trial is to evaluate the effect of an 8-week Whole Body Vibration (WBV) intervention on Bone Mineral Density (BMD), hand grip strength, and vitamin D levels in middle-aged men. Findings from this study will contribute to understanding whether WBV is a viable alternative to conventional exercise, especially for those with limitations in physical activity.

Study Objectives:

• Primary Objective: To assess the effectiveness of an 8-week WBV intervention in improving BMD, hand grip strength, and vitamin D levels compared to a placebo intervention.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

50 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

prince Mutaib bin Abdulaziz hospital

Sakakah, Aljouf, 77634, Saudi Arabia

Location contact

Fahad Alanazi Dr Assitant professor, PhD

CONTACT

Khalid Alrwaily Mr, BPT

CONTACT

[email protected]

+966543944811

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male participants aged 50 years or older
  • Participants with physical activity or exercise program involvement
  • Participants with no history of serious medical conditions such as tumors, fractures, epilepsy, cardiac disease, or stroke within the past year.
  • Participants must be non-smokers and not receiving hormone or calcium supplement therapy

Exclusion criteria

  • Participants unable to stand on the WBV platform
  • Participants with conditions contraindicating vibration therapy
  • Participants participating in other clinical trials

Treatment and study plan

Dynatronics VF5 Model vibration platform

Device

The Dynatronics VF5 Model vibration platform is a specialized therapeutic device designed for rehabilitation and wellness applications. Utilizing advanced vibration technology, it provides whole-body vibration therapy that can enhance muscle strength, improve flexibility, and promote overall physical well-being. The platform features adjustable frequency and amplitude settings, allowing customization based on individual needs. Its user-friendly interface and robust, durable design make it suitable for both clinical and mobile therapy settings. Additionally, the compact and portable nature of the VF5 facilitates easy storage and transport, while safety features such as non-slip surfaces ensure user protection.

Placebo Dynatronics VF5 Model vibration platform

Device

Placebo intensity with vertical vibration of 0.2 mm

Primary outcomes

  1. Bone Density

    Time frame: 8 weeks

    Changes in BMD (measured by DXA scanner),

  2. Grip Strength

    Time frame: 8 weeks

    hand grip strength (measured by a hand-held dynamometer)

  3. Vitamin D

    Time frame: 8 weeks

    Vitamin D levels (measured by high-performance liquid chromatography).

Study contacts

Contact information is provided by the study sponsor or research team.

Fahad Alanazi, PhD

CONTACT

[email protected]

00966503409217

Sponsors and collaborators

Lead sponsor

Jouf University

Other

Registry information

Official study title

Effects of Whole-Body Vibration on Bone Mineral Density, Hand Grip Strength, and Vitamin D Levels in Middle-Aged Men: a Preliminary Clinical Trial

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 16, 2024
Registry last updated
Oct 18, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.